Pseudopoda qizimeishanensis Zhang, J. Liu & Hu, 2024

Pseudopoda qizimeishanensis Zhang, J. Liu & Hu sp. nov.

Figs 1 View Figure 1 , 4 View Figure 4 , 5 View Figure 5 , 6 View Figure 6 , 10 View Figure 10

Type material.

Holotype • male: China, Hubei Province: Enshi Tujia and Miao Autonomous Prefecture, Xuan’en County, Changtanhe Dong Autonomous Township, Qizimeishan National Nature Reserve , Qizimeishan Mountain ; 30 ° 1 ' 45.19 " N, 109 ° 43 ' 45.42 " E; elev. 1270 m; 6–11 July 2023; Changhao Hu & Mian Wei leg. ( CBEE, QZMS 00902 ) GoogleMaps . Paratypes • 8 males and 10 females, with same data as for holotype ( CBEE, QZMS 02441 – QZMS 02458 ) GoogleMaps .

Etymology.

The specific epithet is derived from the type locality, the Qizimeishan Mountain; adjective.

Diagnosis.

The male of P. qizimeishanensis Zhang, J. Liu & Hu , sp. nov. resembles that of P. baoshanensis Zhang, Jäger & Liu, 2023 (cf. fig. 4 A – C vs. fig. 26 A – C in Zhang et al. 2023) by having the expanded E, but can be recognised by: 1) RTA long, arising basally from Ti; 2) T without prolaterad outgrowth; and 3) tip of E pointing 11 o’clock (vs. RTA short, arising medially from Ti, T with prolaterad outgrowth, tip of E pointing 7 o’clock in P. baoshanensis ). The female of P. qizimeishanensis Zhang, J. Liu & Hu , sp. nov. resembles that of P. nanyueensis Tang & Yin, 2000 (cf. fig. 5 A – C vs. figs 2, 3 in Tang and Yin 2000) by: 1) anterior margins of LL V-shaped; 2) anterior margins of LL parallel to posterior margins of LL, but can be recognised by: S long, with wrinkles, almost parallel to anterior margins of LL (vs. S without wrinkles, extending horizontal in P. nanyueensis ).

Male: Measurements: Medium-sized. Body length 14.9, DS length 7.7, width 6.6; OS length 6.8, width 4.8. Eyes: AME 0.29, ALE 0.42, PME 0.25, PLE 0.39, AME – AME 0.26, AME – ALE 0.17, PME – PME 0.46, PME – PLE 0.59, AME – PME 0.37, ALE – PLE 0.39, CH AME 0.72, CH ALE 0.66. Spination: Pp 131, 101, 2111; Fe I – II 323, III 322, IV 321; Pa I – III 101, IV 000; Ti I – II 2226, III – IV 2126; Mt I – II 2024, III 3025, IV 3036. Measurements of palp and legs: Pp 10.1 (3.3, 1.7, 1.9, –, 3.2), I 33.2 (9.3, 3.0, 9.0, 8.9, 3.0), II 34.8 (9.9, 2.8, 9.5, 9.5, 3.1), III 26.6 (7.7, 2.2, 7.3, 7.0, 2.4), IV 29.5 (8.5, 2.2, 7.7, 8.6, 2.5). Leg formula: II-I-IV-III. Promargin of chelicerae with three teeth, retromargin with four teeth, cheliceral furrow with c. 26 denticles.

Palp (Fig. 4 A – C View Figure 4 ): As in diagnosis. C membranous, arising from T at 11 o’clock position. E expanded and plate-like, arising from T at 9 o’clock position; embolic tip curved. RTA arising basally from Ti; vRTA triangular; dRTA long, with two thin teeth in retrolateral view.

Colouration (Fig. 6 A, B View Figure 6 ): DS yellow, with black spots. Ventral legs with black spots. Dorsal OS brown, ventral OS with black spots, spinnerets yellow, with two parallel longitudinal lines of lighter dots.

Female: Measurements: Medium-sized. Body length 16.9, DS length 7.9, width 7.1; OS length 8.6, width 6.6. Eyes: AME 0.33, ALE 0.51, PME 0.31, PLE 0.42, AME – AME 0.32, AME – ALE 0.27, PME – PME 0.58, PME – PLE 0.64, AME – PME 0.44, ALE – PLE 0.41, CH AME 0.60, CH ALE 0.58. Spination: Pp 131, 101, 2121, 1014; Fe I – II 323, III 322, IV 321; Pa I – IV 101; Ti I – IV 2026; Mt I 1014, II – III 2024, IV 3025. Measurements of palp and legs: Pp 9.2 (2.8, 1.1, 2.1, –, 3.2), I 25.6 (7.0, 2.9, 7.0, 6.4, 2.3), II 26.9 (7.9, 2.8, 7.2, 6.8, 2.2), III 22.3 (7.0, 2.7, 5.4, 5.2, 2.0), IV 24.6 (7.6, 2.3, 5.9, 6.5, 2.3). Leg formula: II-I-IV-III. Promargin of chelicerae with three teeth, retromargin with four teeth, cheliceral furrow with c. 26 denticles.

Epigyne (Fig. 5 A – C View Figure 5 ): As in diagnosis. EF as wide as long, with obvious AB. Anterior margins of LL V-shaped. S long and anterolaterally pointed, with wrinkles. FW covering entire S. FD narrow.

Colouration (Fig. 6 C – D View Figure 6 ): As in males, but darker and with a transverse white patch in posterior part of dorsal OS.

Distribution.

China ( Hubei Province) (Fig. 10 View Figure 10 ).